1h Free Analyst Time
The animal intestinal health market is poised to grow by $1587.98 mn during 2023-2027, accelerating at a CAGR of 8.08% during the forecast period. The report on the animal intestinal health market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising awareness regarding animals intestinal health, increase in the industrialization of animal-processed products, and increasing need for feed supplements.
The animal intestinal health market is segmented as below:
By Type
- Probiotics
- Phytogenics
- Prebiotics
- Immunostimulants
By Source
- Plant-based
- Microbial
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
The report on the animal intestinal health market covers the following areas:
- Animal intestinal health market sizing
- Animal intestinal health market forecast
- Animal intestinal health market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Source
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global animal intestinal health market: AB Agri Ltd., Agrihealth Ltd., Alltech Inc., Anco Animal Nutrition Competence, Archer Daniels Midland Co., Arm and Hammer Animal and Food, Beneo GmbH, Bluestar Adisseo Co., Cargill Inc., Chr Hansen Holding AS, Dr. Eckel Animal Nutrition, Evonik Industries AG, International Flavors and Fragrances, Kemin Industries Inc., Land O Lakes Inc., Lesaffre and Cie, Novozymes AS, Nutreco NV, Unique Biotech Ltd., and Koninklijke DSM NV.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rise in the adoption of natural growth promoters.`
According to the report, one of the major drivers for this market is the rising awareness regarding animals intestinal health.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Agri Ltd.
- Agrihealth Ltd.
- Alltech Inc.
- Anco Animal Nutrition Competence
- Archer Daniels Midland Co.
- Arm and Hammer Animal and Food
- Beneo GmbH
- Bluestar Adisseo Co.
- Cargill Inc.
- Chr Hansen Holding AS
- Dr. Eckel Animal Nutrition
- Evonik Industries AG
- International Flavors and Fragrances
- Kemin Industries Inc.
- Land O Lakes Inc.
- Lesaffre and Cie
- Novozymes AS
- Nutreco NV
- Unique Biotech Ltd.
- Koninklijke DSM NV